Scarica l'app Stockscreener
1.4954
2.74%
0.0354
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché OPK Giù?
Forum
Previsione
Opko Health Inc Borsa (OPK) Ultime notizie
COCP: 5 Million Private Placement with OPKO Health - Smartkarma
Is OPK Worth Buying as Valuation Meets Improving Business Trends? - Zacks Investment Research
OPK Raises $125 Million Against Royalties: What Investors Should Know - Yahoo Finance
OPK Climbs 12.4% in the Past Month: Can the Stock Rally Keep Going? - TradingView
Zacks Research Has Positive View of OPKO Health Q3 Earnings - MarketBeat
OPKO Health Secures $125 Million Financing Against Mazdutide Royalties - Yahoo Finance
Should OPKO Health’s Royalty-Backed US$125 Million Financing Shift Matter to OPKO Health (OPK) Investors? - Sahm
OPKO Health (OPK) Retreats to $1.38 as Support at $1.31 Comes into FocusMomentum Surge Alerts - Vinanet
OPKO Health (OPK) Raises $125 Million, Is The Upside Already Priced In? - Sahm
OPKO Health Raises $125 Million in Senior Secured Debt Financing - Minichart
OPKO Health Raises $125M Through Senior Secured Notes Backed by Mazdutide Royalties - Kalkine Media
OPKO Health Raises $125 Million in Additional Royalty-Backed Notes Under Amended HCR Agreement - TradingView
OPKO Health (NASDAQ:OPK) Trading Down 5.4%Here's What Happened - MarketBeat
OPKO Health, Inc. (NASDAQ:OPK) Given Consensus Rating of "Hold" by Analysts - MarketBeat
OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests - OPKO Health, Inc.
OPKO Health, Inc. Expands Strategic Relationship with Healthcare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests - marketscreener.com
OPKO Health secures $125m financing backed by mazdutide royalties - Investing.com Nigeria
OPKO Health Issues Additional $125 Million in Senior Notes Secured by Mazdutide Royalties - marketscreener.com
OPKO Health raises $125M in notes backed by mazdutide royalties - StreetInsider
OPKO Issues $125M Notes While Keeping Future Mazdutide Royalties - Stock Titan
OPKO Health, Inc. announced that it has received $375 million in funding from Healthcare Royalty Management, LLC - marketscreener.com
OPKO Health Inc (OPK) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
Opko Health, Inc. (OPK) Stock Analysis: Exploring A 214.75% Potential Upside - DirectorsTalk Interviews
Does OPKO Health’s Sharply Narrowed Q2 Loss Reset the Bull Case for OPKO Health (OPK)? - Sahm
Opko Health | SCHEDULE 13D: Others - Moomoo
OPKO Health, Inc. Discloses Investment in Cocrystal Pharma with 29.6% Stake - TradingView
OPKO Health: Mazdutide And MDX-2201 Could Change Everything (NASDAQ:OPK) - Seeking Alpha
OPKO Health (OPK) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
OPKO Health invests $5 million in Cocrystal Pharma By Investing.com - Investing.com South Africa
Weekly Recap: Q2 2026 financial results and MDX trial timelines - TradingView
Cocrystal Pharma Raises $5 Million in Private Placement With OPKO Health at $0.9134/Share - TradingView
Cocrystal Pharma (NASDAQ: COCP) secures $5M investment from OPKO Health - Stock Titan
Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health - GlobeNewswire
OPKO Buys 5.47M Cocrystal Shares Ahead of Late-2026 Norovirus Data - Stock Titan
Opko Health Earnings Call Highlights Pipeline, Profit Pivot - The Globe and Mail
Opko Health Launches Early MASH Trial That Could Shape Its Next Growth Chapter - The Globe and Mail
OPKO Health: A Hold As Progress Continues (NASDAQ:OPK) - Seeking Alpha
Opko Health, Inc. Revenue Breakdown – NASDAQ:OPK - TradingView
OPKO Health (OPK) Is Up 14.1% After Narrower Q2 Loss and New 2026 Revenue Guidance – Has The Bull Case Changed? - simplywall.st
Earnings Beat: OPKO Health, Inc. (NASDAQ:OPK) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts - news.futunn.com
OPKO Health FY2026 EPS Estimate Increased by HC Wainwright - MarketBeat
OPKO Health Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Analysts Are Bullish on These Healthcare Stocks: Opko Health (OPK), Atea Pharmaceuticals (AVIR) - The Globe and Mail
OPKO Health (NASDAQ:OPK) Reaches New 52-Week HighHere's Why - MarketBeat
Crude Oil Down Over 5%; Boeing Shares Rise After Q2 Results - Benzinga
OPKO Health (NASDAQ:OPK) Shares Gap Up Following Strong Earnings - MarketBeat
Why Is OPKO Health (NASDAQ:OPK) Stock Drawing Fresh Market Interest Today? - Kalkine Media
Piper Sandler Maintains Opko Health(OPK.US) With Buy Rating, Maintains Target Price $3 - Moomoo
OPK Looks 19.0% Overvalued on GF Value™ - GuruFocus
Opko Health, Inc. (OPK) Stock Analysis: Exploring a 252.82% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
OPKO Health, Inc. 2026 Q2 10-Q Report: Financial Statements, Risk Factors, and Management Discussion - Minichart
OPK Looks 17.9% Overvalued on GF Value™ - GuruFocus
OPKO Health Q2 2026 Results: Key Pipeline Advances, Rayaldee China Expansion, and Improved Financial Performance – Minichart - Minichart
OPKO Health (NASDAQ:OPK) Shares Rise After Q2 Earnings Exceed Forecasts; Nicoya Agreement Lifts After-Hours Gains - TechStock²
Earnings call transcript: OPKO Health posts smaller Q2 loss, shares rise in 2026 - Investing.com Canada
OPK: Q2 2026 delivered higher revenue, improved margins, and raised full-year guidance amid pipeline advances - TradingView
OPKO Health Q2 Earnings Call Highlights - MarketBeat
Compared to Estimates, OPKO Health (OPK) Q2 Earnings: A Look at Key Metrics - Yahoo Finance
OPK: Profitability improved and revenue grew in Q2 2026, with guidance raised for the full year - TradingView
OPK Looks 17.0% Overvalued on GF Value™ - GuruFocus
0.73%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):